Varenzin Oral Suspension - 27ml
Elanco Animal Health |
AH918327HNA

Varenzin Oral Suspension - 27ml

Prescription Product

This is a Schedule 4 (S4) Controlled Substance. Supply is strictly regulated under Australian law. Valid authorisation is required to purchase this product.

Enquire today to create an account

Register
Description

Molidustat oral suspension

Varenzin is approved as an aid in the control of nonregenerative anaemia associated with chronic kidney disease (CKD) in cats.

 

Why choose Varenzin™?​

Varenzin™ is an innovative, easy to give oral​ suspension that safely treats anaemia in cats with CKD.

  • First-in-class solution for feline CKD anaemia
  • Stimulates natural endogenous EPO production
  • Convenient at-home treatment - fish oil flavour1

 

Active ingredient: Molidustat

Target species: Cats

Indication: Varenzin is approved as an aid in the control of nonregenerative anaemia associated with chronic kidney disease (CKD) in cats.

Formulation: Fish oil flavored oral suspension

Voluntary acceptance: 88% of cats voluntarily accepted Varenzin™, indicating high acceptance.1

 

Dosing information

Varenzin™ is administered orally, once daily with a low dosing volume of 0.2 ml/kg (5 mg/kg).
It is available in a 27mL bottle with one dosing syringe included.

 

Weight Range (kg)

Volume of Varenzin™ (ml)

2

0.4

2.1 to 2.5 ​

0.5

2.6 to 3.0

0.6

3.1 to 3.5

0.7

3.6 to 4.0

0.8

4.1 to 4.5

0.9

4.6 to 5.0

1.0

5.1 to 5.5

1.1

5.6 to 6.0

1.2 


For treating cats with a bodyweight greater than 6.0 kg, calculate the dose using 0.2 ml/kg bodyweight and round up to the nearest 0.1 ml.

Additional Information
[Zebravet_Files]:
[Zebravet_Files]
Classification:
S4
Species:
Cat